Hepcvir L Tablet

Hepcvir L Tablet is a combination of Ledipasvir (90 mg) and Sofosbuvir (400 mg), two direct-acting antiviral (DAA) medications used to treat chronic hepatitis C virus (HCV) infection. It works by preventing the virus from multiplying, ultimately leading to its elimination from the body.

Active Ingredients

• Ledipasvir (90 mg) – An NS5A inhibitor that blocks the virus from replicating.
• Sofosbuvir (400 mg) – An NS5B polymerase inhibitor that stops the virus from multiplying further.

Indications

• Treatment of chronic hepatitis C (HCV) infection
• Effective against HCV genotypes 1, 4, 5, and 6
• Helps prevent serious liver diseases such as cirrhosis and liver cancer

Key Benefits

• High cure rate of over 95% when used correctly
• Prevents liver damage and improves liver function
• Fewer side effects compared to older HCV treatments
• Once-daily oral tablet for easy use

Dosage & Administration

• Recommended dose: One tablet per day, with or without food
• Typically prescribed for 12 to 24 weeks, depending on HCV genotype and severity
• Do not skip doses, as it may reduce the effectiveness of treatment

Precautions

• Not recommended if a doctor doesn’t tell you to during pregnancy.
• Avoid alcohol, as it may worsen liver function
• Before using, patients with liver or kidney disease should talk to their doctor.
• Avoid drug interactions with medications like rifampin, amiodarone, and anticonvulsants

Possible Side Effects

Common Side Effects:

• Fatigue
• Headache
• Nausea
• Insomnia

Rare but Serious Side Effects:

• Severe allergic reactions
• Worsening of liver conditions in patients with advanced liver disease

Frequently Asked Questions (FAQ)

1. Can Hepcvir L be taken alone?
No, it is a combination medication but may need to be used with Ribavirin in some cases.

2. How effective is Hepcvir L?
It has a high cure rate of over 95%, especially for HCV genotypes 1 and 4.

3. Can I drink alcohol while taking Hepcvir L?
No, alcohol can worsen liver damage and affect treatment success.